Share on LinkedInShare on LinkedIn

ARTICLE · 16 DECEMBER 2025

UPChronicle - December 2025

Lewis Silkin
Lewis Silkin
Contributor
Lewis Silkin

Lewis Silkin

Joint managing partners: Jo Farmer, Richard Miskella International offices: Dublin, Hong Kong...

View firm profile
Explore more from Lewis Silkin

Welcome to second edition of the UPChronicle. November was a busy month for the Unified Patent Court, with 45 decisions overall and a particularly influential run of 15 decisions and orders from the Court of Appeal...

United KingdomIntellectual Property

Welcome to second edition of the UPChronicle. November was a busy month for the Unified Patent Court, with 45 decisions overall and a particularly influential run of 15 decisions and orders from the Court of Appeal in Luxembourg. A clearer doctrinal framework is emerging across core patent law issues—added matter, sufficiency, claim construction, novelty, and obviousness—anchored by two headline rulings, Amgen v Sanofi and Edwards v Meril. Together, these decisions sharpen the inventive step analysis, confirm a purposive approach to medical use claims that requires therapeutic suitability, and reiterate that injunctions remain the default consequence of proven infringement absent special reasons to the contrary.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from